The overall results confirmed our conjecture that the activation of HERV-K (HML-2) in COVID-19 patients is related to the increase in interferon, thus providing a new idea for the mechanism of interferon production in COVID-19 patients. This evidence concerns the gene CLEC10A and COVID-19.